RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+18.53%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$1.06B
AUM Growth
+$1.06B
(+5.4%)
Cap. Flow
-$43.2M
Cap. Flow
% of AUM
-4.09%
Top 10 Holdings %
Top 10 Hldgs %
34.88%
Holding
95
New
10
Increased
31
Reduced
41
Closed
11
Top Buys
| 1 |
Cigna
CI
|
$32.7M |
| 2 |
Elevance Health
ELV
|
$29.3M |
| 3 |
Becton Dickinson
BDX
|
$28.7M |
| 4 |
Cooper Companies
COO
|
$24.6M |
| 5 |
Penumbra
PEN
|
$9.71M |
Top Sells
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$24.7M |
| 2 |
Medtronic
MDT
|
$23.2M |
| 3 |
Eli Lilly
LLY
|
$18.5M |
| 4 |
Humana
HUM
|
$17.9M |
| 5 |
Danaher
DHR
|
$16.7M |
Sector Composition
| 1 | Healthcare | 99.69% |
| 2 | Industrials | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cigna
CI
$80.3B
| $49.8M | 4.72% | 137,171 +90,171 | +192% | +$32.7M |
|
|
2
Eli Lilly
LLY
$657B
| $42.1M | 3.99% | 54,175 -23,830 | -31% | -$18.5M |
|
3
Tenet Healthcare
THC
$16.3B
| $39.9M | 3.79% | 380,000 +28,370 | +8% | +$2.98M |
|
4
Boston Scientific
BSX
$156B
| $39.9M | 3.78% | 582,000 -168,000 | -22% | -$11.5M |
|
|
5
Elevance Health
ELV
$71.8B
| $36M | 3.42% | 69,500 +56,500 | +435% | +$29.3M |
|
6
AbbVie
ABBV
$372B
| $34.5M | 3.27% | 189,500 +22,500 | +13% | +$4.1M |
|
7
HCA Healthcare
HCA
$94.5B
| $33.4M | 3.16% | 100,000 -9,000 | -8% | -$3M |
|
8
Regeneron Pharmaceuticals
REGN
$61.5B
| $33M | 3.13% | 34,300 -4,700 | -12% | -$4.52M |
|
|
9
Cooper Companies
COO
$13.4B
| $30.5M | 2.89% | 301,000 +242,500 | +415% | +$24.6M |
|
10
Merck
MRK
$210B
| $28.8M | 2.73% | 218,500 +71,000 | +48% | +$9.37M |
|
|
11
Becton Dickinson
BDX
$55.3B
| $28.7M | 2.72% | +116,000 | New | +$28.7M |
|
|
12
Medtronic
MDT
$119B
| $28.3M | 2.68% | 325,000 -266,000 | -45% | -$23.2M |
|
13
Oscar Health
OSCR
$4.31B
| $25.2M | 2.38% | 1,691,522 +499,468 | +42% | +$7.43M |
|
14
Procept Biorobotics
PRCT
$2.23B
| $24.1M | 2.28% | 487,063 +177,063 | +57% | +$8.75M |
|
15
McKesson
MCK
$85.4B
| $23.6M | 2.24% | 44,000 -2,000 | -4% | -$1.07M |
|
16
Vertex Pharmaceuticals
VRTX
$100B
| $23.6M | 2.24% | 56,500 -38,500 | -41% | -$16.1M |
|
17
Natera
NTRA
$23.1B
| $22M | 2.08% | 240,000 -5,000 | -2% | -$457K |
|
18
Abbott
ABT
$231B
| $21M | 1.99% | 185,000 -20,000 | -10% | -$2.27M |
|
|
SWAV
19
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $20.8M | 1.98% | 64,000 -76,000 | -54% | -$24.7M |
|
20
BioMarin Pharmaceuticals
BMRN
$11.2B
| $20.7M | 1.97% | 237,500 -45,000 | -16% | -$3.93M |
|
21
Intuitive Surgical
ISRG
$170B
| $20.2M | 1.91% | 50,500 -13,000 | -20% | -$5.19M |
|
22
UnitedHealth
UNH
$281B
| $20M | 1.9% | 40,500 -13,500 | -25% | -$6.68M |
|
23
DexCom
DXCM
$29.5B
| $19.2M | 1.82% | 138,500 +28,500 | +26% | +$3.95M |
|
24
Jazz Pharmaceuticals
JAZZ
$7.75B
| $17.7M | 1.67% | 146,729 +23,095 | +19% | +$2.78M |
|
25
Royalty Pharma
RPRX
$15.6B
| $16.5M | 1.57% | 544,697 +115,000 | +27% | +$3.49M |
|